Valuation: Acotec Scientific Holdings Limited

Market Cap 2.1B 309M 271M 249M 233M 438M 29.1B 447M 3B 1.16B 14.38B 1.16B 1.13B 49.88B P/E 2026 *
15.6x
P/E 2027 * 12.4x
Enterprise Value 2.1B 309M 271M 249M 233M 438M 29.1B 447M 3B 1.16B 14.38B 1.16B 1.13B 49.88B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.31x
Free-Float
16.21%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 2021-01-28
Chief Tech/Sci/R&D Officer 48 2021-01-28
Chief Tech/Sci/R&D Officer 85 2021-01-28
Director TitleAgeSince
Chairman 54 2021-01-28
Director/Board Member 56 2020-12-02
Director/Board Member 79 2021-01-28
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 310M
+0.28%+0.63%+25.48%-3.36% 12.48B
+2.84%+4.96%+61.12%+32.89% 5.95B
-1.15%+2.49%+7.16%+8.90% 5.61B
-3.16%-2.71% - - 3.99B
-3.75%-5.41%-37.85%+8.18% 3.91B
-1.95%+3.48%-28.15%-26.32% 3.83B
-0.97%-3.62%+50.61%+247.90% 1.81B
+0.86%+11.24%-11.46%-63.52% 1.74B
0.00%+0.37%+58.74%-6.01% 1.54B
Average -0.67%+0.44%+15.71%+24.83% 4.54B
Weighted average by Cap. -0.47%+0.33%+17.02%+12.55%

Financials

2026 *2027 *
Net sales 728M 107M 93.83M 86.49M 80.98M 152M 10.1B 155M 1.04B 402M 4.99B 402M 393M 17.3B 910M 134M 117M 108M 101M 190M 12.62B 194M 1.3B 503M 6.24B 502M 491M 21.63B
Net income 128M 18.82M 16.5M 15.21M 14.24M 26.7M 1.78B 27.25M 183M 70.73M 877M 70.66M 69.11M 3.04B 164M 24.11M 21.14M 19.48M 18.24M 34.21M 2.27B 34.92M 234M 90.62M 1.12B 90.53M 88.55M 3.9B
Net Debt - -
Logo Acotec Scientific Holdings Limited
Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts its businesses within domestic and overseas markets.
Employees
653
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.691CNY
Average target price
15.00CNY
Spread / Average Target
+124.13%

Annual profits - Rate of surprise